| 0 |
Nuclear Export Inhibitor [EPC] |
6 |
0.0007 |
| 1 |
CTLA-4-directed Blocking Antibody [EPC] |
14 |
0.0003 |
| 2 |
Neonatal Fc Receptor Blocker [EPC] |
1 |
0.0002 |
| 3 |
GLP-2 Analog [EPC] |
2 |
0.0001 |
| 4 |
Provitamin D2 Compound [EPC] |
4 |
0.0001 |
| 5 |
Tissue-nonspecific Alkaline Phosphatase [EPC] |
1 |
0.0001 |
| 6 |
Thiazide Diuretic [EPC] |
14 |
0.0001 |
| 7 |
Kinase Inhibitor [EPC] |
31 |
0.0001 |
| 8 |
Topoisomerase Inhibitor [EPC] |
4 |
0.0001 |
| 9 |
Vitamin D3 Analog [EPC] |
1 |
0.0000 |
| 10 |
Poly(ADP-Ribose) Polymerase Inhibitor [EPC] |
1 |
0.0000 |
| 11 |
Angiotensin 2 Receptor Blocker [EPC] |
13 |
0.0000 |
| 12 |
Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] |
1 |
0.0000 |
| 13 |
Dihydropyridine Calcium Channel Blocker [EPC] |
13 |
0.0000 |
| 14 |
beta-Adrenergic Blocker [EPC] |
12 |
0.0000 |
| 15 |
Sympathomimetic-like Agent [EPC] |
1 |
0.0000 |
| 16 |
Alkylating Drug [EPC] |
7 |
0.0000 |
| 17 |
Cholinergic Muscarinic Antagonist [EPC] |
1 |
0.0000 |
| 18 |
Microtubule Inhibitor [EPC] |
4 |
0.0000 |
| 19 |
Anti-IgE [EPC] |
2 |
0.0000 |
| 20 |
General Anesthetic [EPC] |
1 |
0.0000 |
| 21 |
Insulin [EPC] |
1 |
0.0000 |
| 22 |
Corticosteroid [EPC] |
17 |
0.0000 |
| 23 |
Catecholamine [EPC] |
1 |
0.0000 |
| 24 |
Programmed Death Receptor-1 Blocking Antibody [EPC] |
1 |
0.0000 |
| 25 |
Purine Antimetabolite [EPC] |
1 |
0.0000 |
| 26 |
Interleukin-12 Antagonist [EPC] |
1 |
0.0000 |
| 27 |
Interleukin-23 Antagonist [EPC] |
1 |
0.0000 |
| 28 |
CD20-directed Cytolytic Antibody [EPC] |
3 |
0.0000 |
| 29 |
Nonsteroidal Anti-inflammatory Drug [EPC] |
12 |
0.0000 |
| 30 |
Platelet Aggregation Inhibitor [EPC] |
5 |
0.0000 |
| 31 |
Histamine-2 Receptor Antagonist [EPC] |
1 |
0.0000 |
| 32 |
Serotonin-3 Receptor Antagonist [EPC] |
1 |
0.0000 |
| 33 |
Osmotic Laxative [EPC] |
2 |
0.0000 |
| 34 |
Vascular Endothelial Growth Factor Inhibitor [EPC] |
1 |
0.0000 |
| 35 |
Estrogen [EPC] |
1 |
0.0000 |
| 36 |
RANK Ligand Inhibitor [EPC] |
1 |
0.0000 |
| 37 |
Expectorant [EPC] |
1 |
0.0000 |
| 38 |
Vitamin C [EPC] |
2 |
0.0000 |
| 39 |
GLP-1 Receptor Agonist [EPC] |
2 |
0.0000 |
| 40 |
Atypical Antipsychotic [EPC] |
2 |
0.0000 |
| 41 |
Retinoid [EPC] |
1 |
0.0000 |
| 42 |
Nucleoside Metabolic Inhibitor [EPC] |
1 |
0.0000 |
| 43 |
Proton Pump Inhibitor [EPC] |
2 |
0.0000 |
| 44 |
Benzodiazepine [EPC] |
2 |
0.0000 |
| 45 |
Folate Analog Metabolic Inhibitor [EPC] |
1 |
0.0000 |
| 46 |
Insulin Analog [EPC] |
1 |
0.0000 |
| 47 |
Tumor Necrosis Factor Blocker [EPC] |
2 |
0.0000 |